Return to homepagePandemic Pact

Investigating COVID-19 infectiousness and antibody evolution in COVID-19 patients in SSA and Europe

  • Funded by European & Developing Countries Clinical Trials Partnership (EDCTP)
  • Total publications:0 publications

Grant number: RIA2020EF-3008

Grant search

Key facts

  • Disease

    COVID-19

  • Known Financial Commitments (USD)

    $499,605.12

  • Funder

    European & Developing Countries Clinical Trials Partnership (EDCTP)

  • Principal Investigator

    Dr. Julie Fox

  • Research Location

    Uganda, South Africa

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The COVAB project (RIA2020EF-3008) aims to understand antibody evolution following exposure to and/or SARS-CoV-2 infection, and to investigate factors associated with infection by SARS-CoV-2 across oral and nasal mucosa biopsies.